Imiquimod-Induced Cutaneous Lupus-like Reaction: A Potential Histologic Pitfall Highlighting the Importance of Clinico-pathologic Correlation

Brian J Simmons; M Shane Chapman; Konstantinos Linos

doi:10.25251/skin.4.3.19

Brian J Simmons

Dartmouth Hitchcock Medical Center Section of Dermatology Department of Surgery 18 Old Etna Rd Lebanon, NH 03766

M Shane Chapman

Dartmouth-Hitchcock Medical Center Section of Dermatology, Department of Surgery 18 Old Etna Rd Lebanon, NH 03766

Konstantinos Linos

Dartmouth-Hitchcock Medical Center Department of Pathology 1 Medical Center Dr. Lebanon, NH 03756

Keywords

imiquimod, lupus-like, histologic

Abstract

No abstract available.

References

1. Park AJ, Paul J, Chapman MS, Samie FH. Long-Term Outcomes of Melanoma In Situ Treated With Topical 5% Imiquimod Cream: A Retrospective Review. Dermatol Surg. 2017;43(8):1017-1022.

2. Barr KL, Konia TH, Fung MA. Lupus erythematosus-like imiquimod reaction: a diagnostic pitfall. J Cutan Pathol. 2011;38(4):346-350.

3. Chan MP, Zimarowski MJ. Lupus erythematosus-like reaction in imiquimod-treated skin: a report of 2 cases. Am J Dermatopathol. 2011;33(5):523-527.

PDF PDF

Published

May 8, 2020

DOI https://doi.org/10.25251/skin.4.3.19

How to Cite

[1]

Simmons, B.J., Chapman, M.S. and Linos, K. 2020. Imiquimod-Induced Cutaneous Lupus-like Reaction: A Potential Histologic Pitfall Highlighting the Importance of Clinico-pathologic Correlation. SKIN The Journal of Cutaneous Medicine. 4, 3 (May 2020), 300–301. DOI:https://doi.org/10.25251/skin.4.3.19.

Issue

Vol. 4 No. 3 (2020)

Section

Short Communications

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by the following user license:

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.